METTL1 and cancer: Pan-cancer analysis showed that WDR4 and METTL1 were closely related to cancer immune infiltration and were immunotherapy targets in patients, and the high expression of KIRC was associated with poor prognosis of patients (Gao et al., 2022; Zeng et al., 2021).